Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MRPS35 divergent transcript (MRPS35-DT) is an RNA gene distinct from the protein-coding MRPS35 gene. MRPS35-DT is classified as a non-coding RNA (ncRNA), meaning it does not encode a protein. There is no current evidence or characterization suggesting MRPS35-DT functions as a receptor, enzyme, transporter, or other canonical therapeutic target. It is not described as playing a direct role in coding for mitochondrial ribosomal proteins such as 28S ribosomal protein S35 (mitochondrial). While its naming indicates a genomic or transcriptomic relationship to the MRPS35 locus (perhaps from bidirectional or divergent transcription common in ncRNAs), there is no evidence in current gene or protein databases that MRPS35-DT represents a known therapeutic or biological target, nor is it linked to any drugs, mechanisms of drug action, diseases, or biomarker roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRPS35 divergent transcript (MRPS35-DT).